BRCA2 and ovarian carcinoma: Of note, heterozygous BRCA1 inactivation results in genomic instability in nontumorigenic breast epithelial cells [98], and heterozygous mutations in BRCA1 and BRCA2 have been shown to contribute to development of HGSC in an ovarian cancer mouse model [100].